Interestingly, despite the anti-osteogenic properties of MGP, high concentrations were detected in human calcified arteries [33] as coincidently demonstrated in animal models of diabetes and vascular calcification.[34] Therefore, taken together with previous evidence our findings suggest that MGP increase in patients with CAC could possibly reflect a counter-regulatory effect of vascular calcification. This evidence concerns the gene MGP and calcification.